Skip to main content

Idexx Laboratories Inc. Value Stock - Dividend - Research Selection

Idexx

ISIN: US45168D1046 , WKN: 888210

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


IDEXX Laboratories: Recurring Revenue And Market Moat - Why I Choose To Buy

2025-10-02
IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. Click to read why IDXX is a Buy.

IDEXX Laboratories, Inc. (IDXX) Stock Delivers 97% Return in 3 Years, Outpacing Zoetis and Market

2025-10-01
We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. IDEXX Laboratories, Inc. is one of them. IDEXX Laboratories, Inc. (NASDAQ:IDXX) specializes in animal health diagnostics, veterinary software, and laboratory services, supporting companion animals, livestock, water testing, and food safety worldwide. Its platforms, including imaging systems, in-clinic […]

HOLX vs. IDXX: Which Stock Is the Better Value Option?

2025-10-01
HOLX vs. IDXX: Which Stock Is the Better Value Option?

Apple initiated, DraftKings downgraded: Wall Street's top analyst calls

2025-10-01
Apple initiated, DraftKings downgraded: Wall Street's top analyst calls

ImmuCell Announces Selection of its Next President and CEO

2025-09-29
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that it has selected Olivier te Boekhorst as its next President and CEO. The Company anticipates a start date of November 1, 2025 for Mr. te Boekhorst. Mr. te Boekhorst is currently

IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?

2025-09-29
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

2025-09-26
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day

IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors

2025-09-25
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$627 Based On Its Intrinsic Value?

2025-09-25
Key Insights Using the 2 Stage Free Cash Flow to Equity, IDEXX Laboratories fair value estimate is US$467 Current share...

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors

2025-09-24
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors